Loading organizations...
Caozhixing Junbo Equity Investment Partnership: Venture capital firm investing in early-stage startups, focused on biotech and healthtech.
Caozhizxing Junbo Equity Investment Partnership functions as an investment vehicle, deploying capital into private companies. Its core activity involves strategic equity investments aimed at fostering growth and innovation across various sectors. The partnership concentrates on identifying promising enterprises with significant potential for expansion and value creation, providing crucial financial backing.
Specific public details regarding the founding individuals of Caozhizxing Junbo Equity Investment Partnership are not widely available. Operating as a structured limited partnership, it was established to pool capital from investors for strategic private equity allocations. The firm's inception likely arose from a collective understanding of market opportunities within industries requiring growth capital.
The partnership's portfolio companies are direct beneficiaries, receiving essential financial backing to advance their business objectives. While its limited partners remain undisclosed, the firm's long-term vision centers on achieving robust financial returns for its investors through carefully selected, high-potential equity holdings. It aims to contribute to the development of innovative enterprises by providing essential capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 16, 2020 | Enzymaster | $7.5M Series B | — | Tibet Leimerious Venture Investment Partnership, Weifang Zhongke Haichuang Equity Investment Partnership |